Back to Results
First PageMeta Content
Piperazines / Pyrimidines / Orphan drugs / Organofluorides / Pyridines / Chronic myelogenous leukemia / Ponatinib / Philadelphia chromosome / Dasatinib / Chemistry / Biology / Medicine


Gene Therapy and Molecular Biology Vol 16, page 10 Gene Ther Mol Biol Vol 16, 10-29, 2014 Survival assessment and Optimization of BCR/ABL-KD
Add to Reading List

Document Date: 2014-04-08 07:34:01

Open Document

File Size: 661,61 KB

Share Result on Facebook

City

Philadelphia / Thermo ScientificTM / Lahore / ABI / Chicago / /

Company

IBM / BP / Novartis / GenBank / /

Country

Pakistan / United States / Saudi Arabia / /

/

Facility

Jinnah hospital / Mayo hospital / King Saud bin Abdulaziz University / /

IndustryTerm

amplification protocol / mutation analysis protocol / reproducible and amplifiable products / /

MedicalCondition

better disease / disease / blast phase / Chronic / myeloid leukemia / Ph+ Chronic Myeloid Leukemia / fever / murine leukemia / fatigue / stem cell disorder / chronic myeloid leukemia / /

MedicalTreatment

Gene Therapy / drug therapy / /

MusicGroup

DNA / /

Organization

Mayo hospital / ELN / Faculty of Biological Sciences / Department of Zoology / University of the Punjab / Lahore / FDA / Abdulaziz University for Health Sciences / Riyadh / Jinnah hospital / /

Person

Zafar Iqbal / Gene Ther Mol Biol Vol / Hemoglobin / Van Dongen / Muhammad Akram / /

/

Position

Hb / thermal cycler / forward / /

Product

Hydroxyurea / Imatinib / Gleevec / /

ProvinceOrState

Punjab / /

Technology

Gene Therapy / RT-reaction protocol / DNA synthesis / BCR/ABL-KD amplification protocol / DNA sequencing / gel electrophoresis / BCR-ABL-KD mutation analysis protocol / apoptosis / /

SocialTag